Latest Breaking News On - Stifel biotech executive summit - Page 1 : vimarsana.com

/PRNewswire/ Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral.

United statesNew yorkRosalia scampoliKatie mcmanusInternational congressExchange commissionUs drug enforcement agencyTrevi therapeutics incJennifer goodHuman abuse potentialStifel biotech executive summitCantor fitzgerald global healthcare conferenceBiopharma summitTrevi therapeuticsPrivate securities litigation reform actHealth care amp hospitals